Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy
NCT05111860
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Neoadjuvant Treatment
Rectal Cancer
Bevacizumab
Radiotherapy
Interventions
DRUG:
Bevacizumab+mFOLFOX6
Sponsor
Shanghai Minimally Invasive Surgery Center